Phase 1 ALKS 1140 in Healthy Adults

Status:
Recruiting

Trial end date:
2022-10-01

Target enrollment:

Participant gender:

To evaluate the safety and tolerability of ALKS 1140 in healthy adult subjects

Phase 1

Alkermes, Inc.